Breaking News, Promotions & Moves

Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer

Xie will lead the company’s global external innovation strategy in immunology.

Author Image

By: Charlie Sternberg

Associate Editor

Harbour BioMed, a global biopharmaceutical company, has appointed Dr. Jenny Xie as its Chief Scientific Officer, Immunology and Head of Global External Innovation, where she will lead Harbour BioMed’s global external innovation strategy in immunology, managing ongoing strategic collaborations with key partners, as well as identifying and pursuing new partnership opportunities. Additionally, she will oversee all activities at the company’s Harbour BioMed-AstraZeneca Innovation Lab in ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters